CLPTM1L and cancer: These included two novel regions at 2p23.3 (containing e.g. GPN1) and 9q34.12 (LAMC3), as well as two previously known cancer loci at 9p21.3 (CDKN2B-AS1) and 5p15.33 (CLPTM1L).